GSK (GSK) 5-Year EBITDA Growth Rate : 1.00% (As of Dec. 2023)

View and export this data going back to 1987. Start your Free Trial

What is GSK 5-Year EBITDA Growth Rate?

GSK's EBITDA per Share for the three months ended in Dec. 2023 was $0.71.

During the past 12 months, GSK's average EBITDA Per Share Growth Rate was 4.90% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 3.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 1.00% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 1.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of GSK was 96.10% per year. The lowest was -41.40% per year. And the median was 5.70% per year.

Competitive Comparison of GSK's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - General subindustry, GSK's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GSK's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GSK's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where GSK's 5-Year EBITDA Growth Rate falls into.

GSK 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

GSK (NYSE:GSK) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

GSK 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of GSK's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

GSK (GSK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (NYSE:GSK) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

GLAXF:USA GSK N:Mexico GSKl:UK GSK:UK GS71:Germany GS70:Germany GS71:Germany GS70:Germany GS71:Germany G1SK34:Brazil GSK:Argentina

Address

980 Great West Road, Brentford, Middlesex, GBR, TW8 9GS

Website

https://www.gsk.com

In the pharmaceutical industry, GSK ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.